浏览全部资源
扫码关注微信
扫 描 看 全 文
1.湖南省妇幼保健院内科,长沙 410008
2.湖南省妇幼保健院病案管理科,长沙 410008
3.中南大学湘雅公共卫生学院,长沙 410013
4.临床流行病学湖南省重点实验室,长沙 410013
颜雪梅,Email: 510883700@qq.com, ORCID: 0000-0003-2620-4186
陈立章,Email: chenliz@csu.edu.cn, ORCID: 0000-0001-5426-0519
纸质出版日期: 2024-03-28 ,
收稿日期: 2023-12-27 ,
颜雪梅, 肖霞, 孔繁娟, 陈立章. 慢性高血压及其合并妊娠期糖尿病的患病率和妊娠结局[J]. 中南大学学报(医学版), 2024, 49(3): 400-407.
YAN Xuemei, XIAO Xia, KONG Fanjuan, CHEN Lizhang. Prevalence and outcome of chronic hypertension and its complications with gestational diabetes[J]. Journal of Central South University. Medical Science, 2024, 49(3): 400-407.
颜雪梅, 肖霞, 孔繁娟, 陈立章. 慢性高血压及其合并妊娠期糖尿病的患病率和妊娠结局[J]. 中南大学学报(医学版), 2024, 49(3): 400-407. DOI:10.11817/j.issn.1672-7347.2024.230596
YAN Xuemei, XIAO Xia, KONG Fanjuan, CHEN Lizhang. Prevalence and outcome of chronic hypertension and its complications with gestational diabetes[J]. Journal of Central South University. Medical Science, 2024, 49(3): 400-407. DOI:10.11817/j.issn.1672-7347.2024.230596
目的
2
随着中国生育政策全面放开、女性妊娠年龄逐步提高、育龄期超重和肥胖比例逐步增加,慢性高血压(chronic hypertension,CHTN)合并妊娠期糖尿病(gestational diabetes mellitus,GDM)的孕妇比例呈现增多趋势,发生不良妊娠结局风险显著增加。本研究拟分析CHTN及其合并GDM的患病率,并比较二者的不良妊娠结局,旨在为制订干预措施提供依据。
方法
2
本研究为前瞻性研究。根据2016年1月1日至2020年12月31日期间共378 366例大型孕妇队列,筛选出CHTN孕妇1 418例,其中单纯CHTN 1 027例,CHTN合并GDM 391例。应用SAS9.4统计分析孕妇的基本情况、临床资料和妊娠结局,并分析影响CHTN及其合并GDM患者妊娠结局的危险因素。
结果
2
妊娠合并CHTN的患病率为3.8‰,CHTN合并GDM的患病率为1.0‰。CHTN合并GDM患者占所有CHTN孕妇总数的27.57%(391/1 418)。母亲年龄,妊娠次数,产次,既往剖宫产次数,入队列时收缩压、舒张压和平均动脉压在CHTN合并GDM与单纯CHTN 2组间的差异均有统计学意义(均
P
<
0.05)。在调整孕妇年龄、妊娠次数、产次等可能的混杂因素后,二元Logistic回归分析结果显示:CHTN合并GDM孕妇发生剖宫产的危险是CHTN孕妇的1.348倍(
OR
=1.348,95%
CI
1.043~1.741),发生胎盘粘连的危险是CHTN孕妇的2.029倍(
OR
=2.029,95%
CI
1.190~3.462),发生子痫前期的危险是CHTN孕妇的1.540倍(
OR
=1.540,95%
CI
1.101~2.152),结局为巨大儿的危险是CHTN孕妇的2.670倍(
OR
=2.670,95%
CI
1.398~5.100)。
结论
2
CHTN孕妇合并GDM的风险较高,CHTN合并GDM患者的妊娠结局与仅患有CHTN的孕妇在剖宫产、胎盘粘连、子痫前期及巨大儿发生方面存在差异。CHTN合并GDM患者的孕期保健,特别是其血压及血糖的管理更需要重点关注。
Objective
2
With the full liberalization of China’s fertility policy
the gradual increase in maternal age during pregnancy
and the rising proportion of overweight and obesity among women of childbearing age
the number of pregnant women with chronic hypertension (CHTN) combined with gestational diabetes mellitus (GDM) is increasing
leading to a significantly increased risk of adverse pregnancy outcomes. This study aims to analyze the prevalence of CHTN and CHTN complications with GDM
and compare the adverse pregnancy outcomes between the 2 conditions
providing a basis for intervention measures.
Methods
2
This study was a prospective cohort study. A total of 378 366 cases from a large cohort of pregnant women between January 1
2016 to December 31
2020 were screened to identify 1 418 cases of pregnant women with CHTN
among which 1 027 were cases of CHTN alone and 391 were cases of CHTN combined with GDM. SAS9.4 was used to statistically analyze the basic characteristics
clinical data
and pregnant outcomes of pregnant women and to analyze the risk factors affecting the pregnancy outcomes of patients with CHTN and its complications with GDM.
Results
2
The prevalence rate of CHTN with pregnancy was 3.8‰
and the prevalence rate of CHTN combined with GDM was 1.0‰. Patients with CHTN combined with GDM accounted for 27.57% (391/1 418) of all pregnant women with CHTN. Maternal age
number of pregnancies
parity
previous cesarean section
systolic blood pressure
diastolic blood pressure
and mean arterial pressure at the time of enrollment were statistically significant differences between the 2 groups (all
P
<
0.05). After adjusting for potential confounding factors such as maternal age
parity
and number of pregnancies
binary Logistic regression analysis showed that pregnant women with CHTN combined with GDM had a 1.348 times higher risk of cesarean section (
OR
=1.348
95%
CI
1.043 to 1.741)
a 2.029 times higher risk of placental adhesion (
OR
=2.029
95%
CI
1.190 to 3.462)
a 1.540 times higher risk of preeclampsia (
OR
=1.540
95%
CI
1.101 to 2.152)
and a 2.670 times higher risk of macrosomia (
OR
=2.670
95%
CI
1.398 to 5.100) compared to pregnant women with CHTN alone.
Conclusion
2
Pregnant women with CHTN combined with GDM have a high risk
and their pregnancy outcomes differ from those of pregnant women with CHTN alone in terms of cesarean section
placental adhesion
preeclampsia
and macrosomia. Prenatal care for this population
especially the management of blood pressure and blood sugar
needs to be given special attention.
慢性高血压妊娠期糖尿病妊娠结局前瞻性队列研究
chronic hypertensiongestational diabetes mellituspregnancy outcomeprospective cohort study
Al Khalaf SY, O’Reilly ÉJ, Barrett PM, et al. Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: systematic review and meta-analysis[J/OL]. J Am Heart Assoc, 2021, 10(9): e018494[2024-12-01]. https://doi.org/10.1161/jaha.120.018494https://doi.org/10.1161/jaha.120.018494.
吴仕元, 徐繁荣, 肖锦艳, 等. 阿司匹林联合低分子肝素对妊娠合并慢性高血压孕妇母婴结局的影响[J]. 中南医学科学杂志, 2022, 50(1): 102-104. https://doi.org/10.15972/j.cnki.43-1509/r.2022.01.024https://doi.org/10.15972/j.cnki.43-1509/r.2022.01.024.
WU Shiyuan, XU Fanrong, XIAO Jinyan, et al. The effect of aspirin combined with low molecular weight heparin on the outcome of maternal and infant in pregnancy with chronic hypertension[J]. Medical Science Journal of Central South China, 2022, 50(1): 102-104. https://doi.org/10.15972/j.cnki.43-1509/r.2022.01.024https://doi.org/10.15972/j.cnki.43-1509/r.2022.01.024.
Glover AV, Tita AL, Biggio JR, et al. Incidence and risk factors for postpartum severe hypertension in women with underlying chronic hypertension[J]. Am J Perinatol, 2019, 36(7): 737-741. https://doi.org/10.1055/s-0038-1675153https://doi.org/10.1055/s-0038-1675153.
Battarbee AN, Sinkey RG, Harper LM, et al. Chronic hypertension in pregnancy[J]. Am J Obstet Gynecol, 2020, 222(6): 532-541. https://doi.org/10.1016/j.ajog.2019.11.1243https://doi.org/10.1016/j.ajog.2019.11.1243.
Muche AA, Olayemi OO, Gete YK. Gestational diabetes mellitus increased the risk of adverse neonatal outcomes: a prospective cohort study in Northwest Ethiopia[J]. Midwifery, 2020, 87: 102713. https://doi.org/10.1016/j.midw.2020.102713https://doi.org/10.1016/j.midw.2020.102713.
Fill Malfertheiner S, Gutknecht D, Bals-Pratsch M. Preconception optimization of glucose and insulin metabolism in women wanting to conceive-high rate of spontaneous conception prior to planned assisted reproduction[J]. Geburtshilfe Frauenheilkd, 2017, 77(12): 1312-1319. https://doi.org/10.1055/s-0043-122279https://doi.org/10.1055/s-0043-122279.
韩宁, 赵红阳, 徐冬梅. 妊娠期糖尿病孕妇血糖控制状况与围产结局的关系[J]. 郑州大学学报(医学版), 2022, 57(3): 387-391. https://doi.org/10.13705/j.issn.1671-6825.2021.05.139https://doi.org/10.13705/j.issn.1671-6825.2021.05.139.
HAN Ning, ZHAO Hongyang, XU Dongmei, et al. Perinatal outcomes analysis in pregnant women with gestational diabetes
mellitus and different blood glucose control level[J]. Journal of Zhengzhou University. Medical Sciences, 2022, 57(3): 387-391. https://doi.org/10.13705/j.issn.1671-6825.2021.05.139https://doi.org/10.13705/j.issn.1671-6825.2021.05.139.
Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions[J]. Am J Obstet Gynecol, 2012, 206(2): 134-134. https://doi.org/10.1016/j.ajog.2011.10.878https://doi.org/10.1016/j.ajog.2011.10.878.
Zhuang CX, Gao JS, Liu JT, et al. Risk factors and potential protective factors of pregnancy-induced hypertension in China: a cross-sectional study[J]. J Clin Hypertens, 2019, 21(5): 618-623. https://doi.org/10.1111/jch.13541https://doi.org/10.1111/jch.13541.
谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 107.
XIE Xing, KONG Beihua, DUAN Tao. Obstetrics and gynecology[M]. 9th ed. Beijing: People’s Medical Publishing House, 2018: 107.
杨孜, 张为远. 《妊娠期高血压疾病诊治指南(2020)》解读[J]. 中华妇产科杂志, 2020, 55(6): 425-432. https://doi.org/10.3760/cma.j.cn112141-20200302-00159https://doi.org/10.3760/cma.j.cn112141-20200302-00159.
YANG Zi, ZHANG Weiyuan. Interpretation of guidelines for diagnosis and treatment of hypertensive disorders during pregnancy (2020)[J]. Chinese Journal of Obstetrics and Gynecology, 2020, 55(6): 425-432. https://doi.org/10.3760/cma.j.cn112141-20200302-00159https://doi.org/10.3760/cma.j.cn112141-20200302-00159.
Ye C, Ruan Y, Zou LY, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes[J/OL]. PLoS One, 2014, 9(6): e100180[2024-12-01]. https://doi.org/10.1371/journal. pone.0100180https://doi.org/10.1371/journal.pone.0100180.
Gillon TE, Pels A, von Dadelszen P, et al. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines[J/OL]. PLoS One, 2014, 9(12): e113715[2024-12-01]. https://doi.org/10.1371/journal.pone.0113715https://doi.org/10.1371/journal.pone.0113715.
国家心血管病中心, 中国医师学会, 中国医师协会高血压专业委员会, 等. 中国高血压临床实践指南[J]. 中华心血管病杂志, 2022, 50(11): 1050-1095. https://doi.org/10.3760/cma.j.cn112148-20220809-00613https://doi.org/10.3760/cma.j.cn112148-20220809-00613.
National Center for Cardiovascular Diseases, Chinese Medical Doctor Association, Hypertension Committee of the Chinese Medical Doctor Association, et al. Clinical practice guidelines for the management of hypertension in China[J]. Chinese Journal of Cardiology, 2022, 50(11): 1050-1095. https://doi.org/10.3760/cma.j.cn112148-20220809-00613https://doi.org/10.3760/cma.j.cn112148-20220809-00613.
Tita AT, Szychowski JM, Boggess K, et al. Treatment for mild chronic hypertension during pregnancy[J]. N Engl J Med, 2022, 386(19): 1781-1792. https://doi.org/10.1056/NEJMoa2201295https://doi.org/10.1056/NEJMoa2201295.
Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med, 2015, 372(5): 407-417. https://doi.org/10.1056/NEJMoa1404595https://doi.org/10.1056/NEJMoa1404595.
ElSayed NA, Aleppo G, Aroda VR, et al. Management of diabetes in pregnancy: Standards of care in diabetes—2023[J]. Diabetes Care,2023,46(Suppl 1):S254-S266. https://doi.org/10.2337/dc23-S015https://doi.org/10.2337/dc23-S015.
Amornpetchakul P, Lertbunnaphong T, Boriboonhiransarn D, et al. Intravenous carbetocin versus intravenous oxytocin for preventing atonic postpartum hemorrhage after normal vaginal delivery in high-risk singleton pregnancies: a triple-blind randomized controlled trial[J]. Arch Gynecol Obstet, 2018, 298(2): 319-327. https://doi.org/10.1007/s00404-018-4806-5https://doi.org/10.1007/s00404-018-4806-5.
谭春梅, 谭红梅, 易建平, 等. 年龄>35岁孕妇剖宫产产后出血的发生情况及相关影响因素分析[J]. 中国妇幼保健, 2018, 33(23): 5413-5415. https://doi.org/10.7620/zgfybj.j.issn.1001-4411.2018.23.36https://doi.org/10.7620/zgfybj.j.issn.1001-4411.2018.23.36.
TAN Chunmei, TAN Hongmei, YI Jianping, et al. Prevalence of postpartum hemorrhage in pregnant women over 35 years old after cesarean section and analysis on the related influencing factors[J]. Maternal and Child Health Care of China, 2018, 33(23): 5413-5415. https://doi.org/10.7620/zgfybj.j.issn.1001-4411.2018.23.36https://doi.org/10.7620/zgfybj.j.issn.1001-4411.2018.23.36.
杜淑玲. 高龄产妇产后出血的影响因素及预防措施[J]. 中国计划生育学杂志, 2019, 27(4): 530-532. https://doi.org/10. 3969/j.issn.1004-8189.2019.04.032https://doi.org/10.3969/j.issn.1004-8189.2019.04.032.
DU Shuling. Influencing factors and preventive measures of postpartum hemorrhage in elderly women[J]. Chinese Journal of Family Planning, 2019, 27(4): 530-532. https://doi.org/10. 3969/j.issn.1004-8189.2019.04.032https://doi.org/10.3969/j.issn.1004-8189.2019.04.032.
Ram M, Berger H, Geary M, et al. Timing of delivery in women with chronic hypertension[J]. Obstet Gynecol, 2018, 132(3): 669-677. https://doi.org/10.1097/AOG.0000000000002800https://doi.org/10.1097/AOG.0000000000002800.
Tsakiridis I, Giouleka S, Arvanitaki A, et al. Chronic hypertension in pregnancy: synthesis of influential guidelines[J]. J Perinat Med, 2021, 49(7): 859-872. https://doi.org/10. 1515/jpm-2021-0015https://doi.org/10.1515/jpm-2021-0015.
Walker KF, Thornton JG. Timing and mode of delivery with advancing maternal age[J]. Best Pract Res Clin Obstet Gynaecol, 2021, 70: 101-111. https://doi.org/10.1016/j.bpobgyn. 2020.06.005https://doi.org/10.1016/j.bpobgyn.2020.06.005.
Hulman A. Comment on scholtenset Al. hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal glycemia and childhood glucose metabolism[J/OL]. Diabetes Care, 2019, 42(7): e127[2024-12-01]. https://doi.org/10.2337/dc19-0650https://doi.org/10.2337/dc19-0650.
Weiss R, Santoro N, Giannini C, et al. Prediabetes in youth—mechanisms and biomarkers[J]. Lancet Child Adolesc Health, 2017, 1(3): 240-248. https://doi.org/10.1016/S2352-4642(17)30044-5https://doi.org/10.1016/S2352-4642(17)30044-5.
American Diabetes Association. Management of diabetes in pregnancy[J]. Diabetes care, 2015, 38: S77-S79. https://doi.org/10.2337/dc15-S015https://doi.org/10.2337/dc15-S015.
Kim SY, England L, Wilson HG, et al. Percentage of gestational diabetes mellitus attributable to overweight and obesity[J]. Am J Public Health, 2010, 100(6): 1047-1052. https:// doi.org/10.2105/AJPH.2009.172890https://doi.org/10.2105/AJPH.2009.172890.
Lin PC, Hung CH, Chan TF, et al. The risk factors for gestational diabetes mellitus: a retrospective study[J]. Midwifery, 2016, 42: 16-20. https://doi.org/10.1016/j.midw. 2016.09.008https://doi.org/10.1016/j.midw.2016.09.008.
0
浏览量
5
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构